深度学习模型在磁共振成像上自动检测、定位和表征临床显著性前列腺癌诊断准确性的系统综述
本系统综述检索2020年1月至2023年9月Medline/PubMed、Embase、Web of Science和ScienceDirect,纳入25项验证全自动深度学习模型用于磁共振成像检测临床显著性前列腺癌并经病理确认的研究。结果显示模型在检测和表征临床显著性前列腺癌方面有前景,但研究设计、验证策略和数据集异质性大,仅三分之一研究进行外部验证,限制泛化性。结论支持谨慎整合人工智能进入临床实践,需进一步研究确认其在不同临床环境中的效能。
要点
- 25项研究显示深度学习模型在MRI上检测和表征临床显著性前列腺癌有前景。
- 仅三分之一研究进行外部验证,内部验证限制泛化性。
- 研究设计、验证策略和数据集异质性大,缺乏标准化方法阻碍临床整合。
核心结论
- 深度学习模型在改善MRI前列腺癌诊断方面显示显著潜力,但验证、泛化性和临床实施方面的挑战必须解决。
- 未来研究应聚焦标准化方法、确保外部验证并进行前瞻性临床试验,以促进人工智能在常规临床环境中的采用。
- 这些发现支持谨慎地将人工智能整合到临床实践中,需要进一步研究确认其在不同临床环境中的效能。
研究设计与样本
- 系统综述,检索Medline/PubMed、Embase、Web of Science和ScienceDirect中2020年1月至2023年9月发表的研究。
- 纳入标准为呈现并验证全自动深度学习模型用于MRI上临床显著性前列腺癌检测且经病理确认的研究。
- 使用QUADAS-2工具和医学影像人工智能检查表评估研究质量。
- 共25项研究符合纳入标准。
主要发现
- 25项研究在检测和表征临床显著性前列腺癌方面显示有前景的结果。
- 研究设计、验证策略和数据集存在显著异质性,使直接比较复杂化。
- 仅三分之一研究进行了外部验证。
- 依赖内部验证限制了这些发现的更广泛应用。
- 缺乏标准化方法阻碍深度学习模型整合到临床实践中。
临床怎么用
- 这些发现支持谨慎地将人工智能整合到临床实践中,需要进一步研究确认其在不同临床环境中的效能。
局限性
- 研究设计、验证策略和数据集存在显著异质性,使直接比较复杂化。
- 仅三分之一研究进行了外部验证,凸显泛化性的关键差距。
- 依赖内部验证限制了这些发现的更广泛应用。
- 缺乏标准化方法阻碍深度学习模型整合到临床实践中。
- 需要进一步研究确认其在不同临床环境中的效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Magnetic resonance imaging (MRI) plays a critical role in prostate cancer diagnosis, but is limited by variability in interpretation and diagnostic accuracy. This systematic review evaluates the current state of deep learning (DL) models in enhancing the automatic detection, localization, and characterization of clinically significant prostate cancer (csPCa) on MRI. METHODS: A systematic search was conducted across Medline/PubMed, Embase, Web of Science, and ScienceDirect for studies published between January 2020 and September 2023. Studies were included if these presented and validated fully automated DL models for csPCa detection on MRI, with pathology confirmation. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool and the Checklist for Artificial Intelligence in Medical Imaging. KEY FINDINGS AND LIMITATIONS: Twenty-five studies met the inclusion criteria, showing promising results in detecting and characterizing csPCa. However, significant heterogeneity in study designs, validation strategies, and datasets complicates direct comparisons. Only one-third of studies performed external validation, highlighting a critical gap in generalizability. The reliance on internal validation limits a broader application of these findings, and the lack of standardized methodologies hinders the integration of DL models into clinical practice. CONCLUSIONS AND CLINICAL IMPLICATIONS: DL models demonstrate significant potential in improving prostate cancer diagnostics on MRI. However, challenges in validation, generalizability, and clinical implementation must be addressed. Future research should focus on standardizing methodologies, ensuring external validation and conducting prospective clinical trials to facilitate the adoption of artificial intelligence (AI) in routine clinical settings. These findings support the cautious integration of AI into clinical practice, with further studies needed to confirm their efficacy in diverse clinical environments. PATIENT SUMMARY: In this study, we reviewed how artificial intelligence (AI) models can help doctors better detect and understand aggressive prostate cancer using magnetic resonance imaging scans. We found that while these AI tools show promise, these tools need more testing and validation in different hospitals before these can be used widely in patient care.
引用
- Molière S, Hamzaoui D, Ploussard G, et al. A Systematic Review of the Diagnostic Accuracy of Deep Learning Models for the Automatic Detection, Localization, and Characterization of Clinically Significant Prostate Cancer on Magnetic Resonance Imaging. Eur Urol Oncol. 2024. PMID: 39547898. doi:10.1016/j.euo.2024.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。